Cargando…

Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy

Dysregulated miRNA expression and mutation of genes involved in miRNA biogenesis have been reported in motor neuron diseases including spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). Therefore, identifying molecular mechanisms governing miRNA expression is important to underst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonçalves, Inês do Carmo G., Brecht, Johanna, Thelen, Maximilian P., Rehorst, Wiebke A., Peters, Miriam, Lee, Hyun Ju, Motameny, Susanne, Torres-Benito, Laura, Ebrahimi-Fakhari, Darius, Kononenko, Natalia L., Altmüller, Janine, Vilchez, David, Sahin, Mustafa, Wirth, Brunhilde, Kye, Min Jeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962575/ https://www.ncbi.nlm.nih.gov/pubmed/29784949 http://dx.doi.org/10.1038/s41598-018-26347-y

Ejemplares similares

Author Correction: Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy
por: Gonçalves, Inês do Carmo G., et al.
Publicado: (2018)

Author Correction: Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy
por: Gonçalves, Inês do Carmo G., et al.
Publicado: (2020)

Muscle regulates mTOR dependent axonal local translation in motor neurons via CTRP3 secretion: implications for a neuromuscular disorder, spinal muscular atrophy
por: Rehorst, Wiebke A., et al.
Publicado: (2019)

Mitochondrial Dysfunction in Spinal Muscular Atrophy
por: Zilio, Eleonora, et al.
Publicado: (2022)

Mitochondrial defects in the respiratory complex I contribute to impaired translational initiation via ROS and energy homeostasis in SMA motor neurons
por: Thelen, Maximilian Paul, et al.
Publicado: (2020)

Dominant spinal muscular atrophy is caused by mutations in BICD2, an important golgin protein
por: Martinez-Carrera, Lilian A., et al.
Publicado: (2015)

Tongue fasciculations in an infant with spinal muscular atrophy type 1
por: Giannopoulou, Eleni Z, et al.
Publicado: (2015)

CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis
por: Janzen, Eva, et al.
Publicado: (2018)

Maximum bite force in patients with spinal muscular atrophy during the first year of nusinersen therapy – A pilot study
por: Kruse, Teresa, et al.
Publicado: (2020)

Genetic modifiers ameliorate endocytic and neuromuscular defects in a model of spinal muscular atrophy
por: Walsh, Melissa B., et al.
Publicado: (2020)

Decreased microRNA levels lead to deleterious increases in neuronal M2 muscarinic receptors in Spinal Muscular Atrophy models
por: O'Hern, Patrick J, et al.
Publicado: (2017)

Central synaptopathy is the most conserved feature of motor circuit pathology across spinal muscular atrophy mouse models
por: Buettner, Jannik M., et al.
Publicado: (2021)

Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years
por: Vill, Katharina, et al.
Publicado: (2021)

Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition
por: Hauke, Jan, et al.
Publicado: (2009)

The Proteome Signatures of Fibroblasts from Patients with Severe, Intermediate and Mild Spinal Muscular Atrophy Show Limited Overlap
por: Brown, Sharon J., et al.
Publicado: (2022)

Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice
por: Strathmann, Eike A., et al.
Publicado: (2018)

UBA1/GARS-dependent pathways drive sensory-motor connectivity defects in spinal muscular atrophy
por: Shorrock, Hannah K, et al.
Publicado: (2018)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Progressive Muscular Atrophy
por: Omar, A.
Publicado: (1947)

Progressive Muscular Atrophy
por: Omar, A.
Publicado: (1947)

Progressive Muscular Atrophy
por: Omer, M. A.
Publicado: (1949)

Muscular Atrophy and Sclerodermia
por: Nixon, J. A.
Publicado: (1903)

Progressive Muscular Atrophy
Publicado: (1874)

Muscular Atrophy and Sclerodermia
Publicado: (1904)

Acute Muscular Atrophy
por: Haddon, John
Publicado: (1870)

Case of Muscular Atrophy
por: Kersey, V.
Publicado: (1871)

Neurocalcin Delta Knockout Impairs Adult Neurogenesis Whereas Half Reduction Is Not Pathological
por: Upadhyay, Aaradhita, et al.
Publicado: (2019)

Case of Marked Muscular Atrophy of Hands and Fore-Arms—Progressive Muscular Atrophy(?)
por: Ness, R. Barclay
Publicado: (1895)

Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening – Opportunity or Burden?(1)
por: Müller-Felber, Wolfgang, et al.
Publicado: (2020)

Objective measurement of oral function in adults with spinal muscular atrophy
por: Kruse, T., et al.
Publicado: (2023)

Cytoplasmic Drosha activity generated by alternative splicing
por: Dai, Lisheng, et al.
Publicado: (2016)

Alternative splicing affects the subcellular localization of Drosha
por: Link, Steffen, et al.
Publicado: (2016)

Towards Understanding the Pathogenicity of DROSHA Mutations in Oncohematology
por: Bug, Dmitrii S., et al.
Publicado: (2021)

Pseudo-Muscular Hypertrophy and Its Relations to Muscular Atrophy
Publicado: (1875)

Neuronal involvement in muscular atrophy
por: Cisterna, Bruno A., et al.
Publicado: (2014)

Muscular Atrophies in Joint Disease
Publicado: (1904)

Progressive Muscular Atrophy with Recovery
por: Clarke, J. Michell
Publicado: (1888)

Muscular Atrophy in Tabes Dorsalis
Publicado: (1889)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4d8ie34ctfkhog25h4beikt5n0